Lv4
800 积分 2021-02-07 加入
Derivation and validation of a novel score for early prediction of severe CRS after CAR‐T therapy in haematological malignancy patients: A multi‐centre study
6天前
已完结
Basics of apheresis and equipment
16天前
已完结
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Hemophagocytic Lymphohistiocytosis After CAR T‐Cell Therapy: A Systematic Review and Meta‐Analysis
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
1个月前
已完结
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
1个月前
已完结
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
8个月前
已完结
Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity
10个月前
已完结
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
11个月前
已完结
皖公网安备34019202002308
